Tvardi Therapeutics Inc. sell Lokrim
Start price
13.10.25
/
20%
€5.17
Target price
13.10.26
-
Performance (%)
-58.61%
Price
17.04.26
€2.14
Summary
This prediction is currently active. The SELL prediction by Lokrim for Tvardi Therapeutics Inc. is performing very well with a performance of -58.61%. This prediction currently runs until 13.10.26. The prediction end date can be changed by Lokrim at any time. Lokrim has 20% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Tvardi Therapeutics Inc. | - | - |
| iShares Core DAX® | 3,59 % | 3,93 % |
| iShares Nasdaq 100 | 5,81 % | 5,52 % |
| iShares Nikkei 225® | 4,08 % | 8,46 % |
| iShares S&P 500 | 4,14 % | 4,04 % |
According to Lokrim what are the pros and cons of Tvardi Therapeutics Inc. for the foreseeable future?
Pros
Cons
Probably not worthwhile Investment
Comments by Lokrim for this prediction
In the thread Tvardi Therapeutics Inc. diskutieren
Sell Tvardi Therapeutics Inc.

